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We prospectively investigated non-
invasive selective brain cooling (SBC) in
patients with severe traumatic brain
injury. Sixty-six in-patients were
randomized into three groups. In one
group, brain temperature was maintained
at 33 – 35 °C by cooling the head and neck
(SBC); in a second group, mild systemic
hypothermia (MSH; rectal temperature 
33 – 35 °C) was produced with a cooling
blanket; and a control group was not
exposed to hypothermia. Natural re-
warming began after 3 days. Mean
intracranial pressure 24, 48 or 72 h after
injury was significantly lower in the SBC
group than in the control group. Mean
serum superoxide dismutase levels on Days
3 and 7 after injury in the SBC and MSH
groups were significantly higher than in
the control group. The percentage of
patients with a good neurological outcome
2 years after injury was 72.7%, 57.1% and
34.8% in the SBC, MSH and control groups,
respectively. Complications were managed
without severe sequelae. Non-invasive SBC
was safe and effective.
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Introduction
Severe traumatic brain injury (TBI) is a major
cause of permanent disability in adults after
trauma in spite of recent advances in
treatment.1 – 4 Mild hypothermia (33 – 35 °C),
one of the current therapies designed to
combat the deleterious effects of TBI, helps 
to protect the brain and reduces mortality 
in severe TBI.2 – 6 Since mild systemic
hypothermia (MSH) leads to adverse side-
effects such as severe secondary infections
and shock during re-warming, selective brain
cooling (SBC) has been investigated for rapid
local hypothermia.5,7 Despite its promise, the
clinical benefits of SBC have rarely been
investigated.5 In order to evaluate the effects
of SBC in patients with severe TBI, we
conducted a randomized, controlled clinical
trial of SBC, MSH and normothermia in
patients with severe TBI, and the clinical
effects were analysed prospectively.
Patients and methods
PATIENT GROUPS
This clinical study was designed as a
randomized, controlled, double-blind trial.
After informed consent had been obtained
 
from the patients’ families, each patient was
assigned to one of three groups according to a
randomization table. Two groups received
treatment to produce hypothermia (SBC or
MSH); the third group was not exposed to
hypothermia and constituted the control
group. All the patients met the following
criteria: a history of TBI, Glasgow Coma Scale
score ≤ 8 at admission, and brain injury
apparent on sequential computed tomography
within 1 – 24 h (mean 8.6 h) of admission.
The research protocol was approved by
the Clinical Research Ethics Committee of
our university, and the principles of the
Declaration of Helsinki were followed strictly. 
TREATMENTS
All patients either underwent local
decompression or were managed non-
surgically, such as with dehydration.
In the SBC group, we began therapy
directly on admission or after craniotomy,
and applied it on each of three successive
days for 0 – 6 h (average 4.5 h) according to
the patient’s condition. SBC was induced by
fitting a cooling cap around the head, in
which water at about 4 °C was circulating,
and a neckband containing blue ice strips
(BWB-10; BWKJ, Fujian, China) was placed
around the neck. The cold water was cycled
by a hypothermia machine (KN-01; EBM,
Beijing, China), and fresh blue ice strips were
placed in the interlayer of the neckband
(using a strap with which the neckband
could be loosened or tightened as needed) 
at intervals of 3 – 4 h according to the
temperature of the patient and the thawing
time of the ice strips. In this way, brain
temperature could be reduced to 33 – 35 °C
(within 2 h in most patients) and
maintained in this temperature range. In
patients who shivered, artificial hibernation
mixture (20 ml normal saline + 100 mg
chlorpromazine + 100 mg promethazine)
was introduced intravenously at 2 – 10 ml/h.
In the MSH group, a cooling blanket and
refrigerated ice-bags were used continuously
to maintain rectal temperature at about 
33 – 35 °C; the same artificial hibernation
mixture as that used in the SBC group was
used if necessary.
When hypothermia treatment terminated
after 3 days, the temperature was expected
to return to baseline spontaneously.
The normothermia control group received
the same conventional treatment as the
hypothermia groups, but they were not
exposed to hypothermia.6
MONITORING PARAMETERS
The following parameters were monitored at
admission or after operation:6
(i) Brain and rectal temperatures, using the
KN-01 monitoring system (EBM, Beijing,
China);
(ii) Intracranial pressure (ICP), using the
SJN208l monitoring system (Gelan,
Beijing, China);
(iii) Heart rate, breathing rate, blood pressure
and arterial blood oxygen saturation,
using multiple monitors (Model 90309;
Space Labs, Redmond, WA, USA); 
(iv) Blood superoxide dismutase (SOD), by
radioimmunoassay; 
(v) Complications, including pulmonary
infection, digestive tract haemorrhage,
thrombocytopenia (platelet count less
than 100 × 109/l) and disturbance of
electrolytes; and
(vi) The Glasgow Outcome Scale (GOS) score
(1 = death, 2 = vegetative state, 3 = severe
disability, 4 = moderate disability, 5 =
mild or no disability), evaluated at 
2 years of follow-up after injury.
STATISTICAL ANALYSIS
The ICP and SOD levels are presented as
mean ± SD, and were subjected to one-way
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ANOVA (analysis of variance) if variances
were equal; the Student–Newman–Keuls test
was used to compare groups if differences
within groups were significant. The rates of
fatality and good recovery in the three groups
were compared using the Pearson χ2 test for
multiple samples, as appropriate. Differences
in outcome between groups were evaluated
with the Cochran–Mantel–Haenszel test.
Data were analysed using SAS® statistical
software (version 8; SAS Institute, Cary, NC,
USA). A P-value < 0.05 was considered to
indicate a significant difference.
Results
The study population consisted of 66 adult
in-patients with severe TBI admitted to our
department during 2003 and 2004; 42
patients were male and 24 were female, and
their ages ranged from 19 to 65 years (40.6 ±
10.3). There were 22 patients in the SBC
group, 21 in the MSH group and 23 in the
normothermic control group. The main
characteristics of the patients, which did not
differ significantly between groups, are
shown in Table 1.
BRAIN AND RECTAL TEMPERATURES
During hypothermia, in the group exposed
to SBC the brain surface temperature was
maintained between 33 and 35 °C and rectal
temperature between 36.5 and 37.5 °C; in 
the MSH group brain surface and rectal
temperatures were about 35 and 37 °C,
respectively. When hypothermia treatment
was stopped in the SBC and MSH groups
(after 3 days), brain temperature returned to
baseline within 0.5 – 2.6 h and rectal
temperature did so within 2.3 – 13.2 h. In the
control group (normothermia), brain and
rectal temperatures remained at about 37 °C
throughout. 
INTRACRANIAL PRESSURE
The ICP values of the groups receiving
hypothermia were significantly lower 24, 48
and 72 h after injury than those of the
control group (P < 0.05; Table 2). No
significant differences were observed
between the ICPs of the two hypothermia
groups (SBC and MSH) at corresponding
time points after initiation of hypothermia.
The highest ICP was observed 48 h after
injury in all three groups, which is consistent
with previous studies.6
SERUM SOD LEVELS
As shown in Table 3, the serum SOD levels of
the two groups receiving hypothermia had
increased sharply on Days 3 and 7 after
injury compared with levels before
hypothermia. In the SBC group the increases
were 45% and 76% on the 2 days,
respectively, and in the MSH group they 
were 60% and 86%, respectively (linear
correlations: Day 3, r = 0.948 in the SBC
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No. of Gender Mean age Injury type GCS Surgery
Group patients Male/female (years) Traffic accident/other 3 – 5/6 – 8 Yes/no
SBC 22 14/8 40.2 13/9 12/10 18/4
MSH 21 12/9 39.6 15/6 11/10 16/5
Control 23 16/7 42.3 16/7 14/9 17/6
GCS, Glasgow Coma Score.
TABLE 1:
Clinical characteristics of groups of patients treated for 3 days with selective brain cooling
(SBC), mild systemic hypothermia (MSH) or normothermia (control) after severe
traumatic brain injury
Group 24 h after injury 48 h after injury 72 h after injury
SBC 27.38 ± 5.25a 29.18 ± 6.75a 26.70 ± 4.50a
MSH 27.08 ± 4.50 29.70 ± 3.08 26.48 ± 3.75
Control 32.63 ± 3.10 34.80 ± 6.00 31.81 ± 4.50
aP < 0.05 versus control group.
Values are mean ± SD. 
TABLE 2:
Changes in intracranial pressure (mmHg) in groups of patients treated for 3 days with
selective brain cooling (SBC), mild systemic hypothermia (MSH) or normothermia
(control) after severe traumatic brain injury
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group and 0.965 in the MSH group; Day 7, 
r = 0.968 in the SBC group and 0.906 in the
MSH group, respectively). Although the SOD
levels in the two hypothermia groups were
not significantly different at corresponding
time points after treatment, for each of these
groups the difference with respect to the
control (normothermia) group was highly
significant (P < 0.01).
NEUROLOGICAL OUTCOMES
The GOS scores 2 years after injury indicated
significant differences in overall neurological
outcome between the three groups (Table 4).
The frequency of mild or no disability did 
not differ significantly between the two
hypothermia groups (SBC and MSH), but
was significantly higher than in the 
control (normothermia) group (P < 0.05).
Furthermore, the frequency of good
neurological outcome (GOS score 4 or 5) in
the SBC and MSH groups was significantly
higher than that in the control group (72.7,
57.1 and 34.8%, respectively; P < 0.05)
(Table 4). The mortality rates in the SBC and
MSH groups were significantly lower than in
the control group (P < 0.05).
COMPLICATIONS
No evidence of severe complications related
to hypothermia was found. There were five
cases (22.7%) of pneumonia in the SBC
group, eight cases (38.1%) in the MSH group
and eight cases (34.8%) in the control group.
There was no significant difference between
the platelet counts of the SBC and MSH
Group Day 1 Day 3 Day 7
SBC 387.1 ± 160.2 562.5 ± 98.8a 683.2 ± 236.2a
MSH 376.5 ± 159.4 602.4 ± 103.5a 701.2 ± 193.4a
Control 368.6 ± 171.4 446.6 ± 79.5 497.1 ± 101.2
aP < 0.01 versus control group. 
Values are mean ± SD. 
The normal reference range for superoxide dismutase is 235 – 535 µg/l.
TABLE 3:
Dynamic changes in serum superoxide dismutase (µg/l) levels at different intervals after
severe traumatic brain injury in groups of patients treated for 3 days with selective brain
cooling (SBC), mild systemic hypothermia (MSH) or normothermia (control)
No. of Mild or no Moderate Severe Vegetative
Group patients disability disability disability state Death
SBC 22 12 (54.5)a 4 (18.2) 1 (4.5) 0 5 (27.3)a
MSH 21 11 (52.4) 1 (4.8) 3 (14.3) 0 6 (28.6)
Control 23 6 (26.1) 2 (8.7) 3 (13.0) 0 12 (52.2)
aP < 0.05 versus control group.
Data are numbers (%) of patients. χ2 = 6.0081, P < 0.05 between groups.
TABLE 4:
Clinical outcome at 2 years of follow-up in groups of patients treated for 3 days with
selective brain cooling (SBC), mild systemic hypothermia (MSH) or normothermia
(control) after severe traumatic brain injury
groups, but thrombocytopenia occurred in
72.7% (16/22) and 66.7% (14/21) of patients
in the SBC and MSH groups, respectively.
Although thrombocytopenia was more
common in the two hypothermia groups
than in the control group (39.1%, nine of
23), all of the platelet counts during
hypothermia returned to normal within 
3 days after the termination of hypothermia.
The rates of haemorrhage in the digestive
tract and renal malfunction did not differ
significantly among the groups. All
complications were treated and improved
without severe sequelae. There was no severe
abnormality of heart rate, breathing rate,
blood pressure, arterial blood gas analysis or
blood electrolytes in any group.
Discussion
Hypothermia protects brain tissue after TBI,
mainly by limiting ICP, preventing or
alleviating secondary brain injury and thus
improving cerebral perfusion pressure.1 – 4
Hypothermia also has positive effects on
primary brain injury by facilitating the
restoration of membrane function and
attenuating cytoskeletal damage and by
other means.8
Generally speaking, there are two ways of
inducing brain hypothermia: by systemic
(whole-body) cooling and local (selective)
cooling. Owing to the confirmed severe
adverse complications, such as shock on
rewarming, increased cardiac ischaemia
perioperatively and a tendency to bleed even
with a normal haemostatic test in patients
receiving MSH,9 SBC has been investigated
and applied in clinical studies to maximize
neuroprotection while minimizing systemic
complications.10
There are different methods of achieving
SBC. Hagioka et al.11 reported that naso-
pharyngeal cooling with physiological saline
(5%) enables the rapid and selective reduction
of brain temperature. Noguchi et al.12
concluded that producing SBC by perfusion of
saline into the subdural space was effective
and might be used in neurosurgery. Furuse et
al.13 showed that perfusion of the carotid
artery was another way of producing SBC.
Rapid induction of cooling by intravenous
administration of cold crystalloid is another
technique.3,7,14 Recently, Ding et al.14 described
the production of SBC by regional cooling
with local infusion of saline into ischaemic
brain territory; in their in vivo study, pre-
reperfusion infusion effectively induced
hypothermia and ameliorated brain injury. It
has been demonstrated that early head
cooling is effective in preventing some of the
earliest brain damage, even in the absence of
profound systemic hypothermia.15
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Although cooling can be induced more
efficiently by an endovascular approach
than by a surface approach, the placement
of an effective central venous or jugular
endovascular device requires additional
techniques and operating time.7 However,
this approach may not be readily feasible 
in most clinical settings at present.
Nasopharyngeal cooling or intraoperative
cooling of the subdural space had a limited
effect in lowering the brain temperature of
adult patients.1,3,5 Since surface cooling with
a fluid-filled helmet is not a reliable way of
reducing core temperature, we produced SBC
by combining a cold-water cap with an ice
strap around the neck. The results
demonstrate that our non-invasive method
of inducing SBC was effective. First, the brain
temperature in the SBC group was lowered
to 33 – 35 °C in less than 2 h, while rectal
temperature remained at about 37 °C; thus,
complications in other organs due to
vasoconstriction during hypothermia may
have been prevented. We decided that
hypothermia should be applied as soon as
possible, except in patients with contra-
indications.1 – 8,13,16 A possible advantage 
of SBC over MSH is more rapid local
hypothermia, because the tissues with
decreased perfusion as a result of
physiological manipulation or local trauma
may be more susceptible to local
temperature changes.10 – 15 Secondly, in the
group receiving SBC the ICP was
significantly lower (to a similar extent to
that in the MSH group) than that in the
normothermia control group at each time
point. Since the ICP of the SBC group was
much lower, this could theoretically improve
the neurological prognosis. Thirdly, the
serum levels of SOD in the SBC and MSH
groups on Days 3 and 7 after injury were
significantly higher than those in the
normothermia control group. This implies
that hypothermia could inhibit the
generation of free radicals and could
alleviate lipid peroxidation.17 Statistically
significant benefits were observed in
survival and neurological outcome in
patients treated with SBC and the mortality
rate was lower than in previous studies.18
Lastly, no confirmed evidence of a
relationship between severe complications
and therapeutic hypothermia was found.
The present study has some shortcomings.
The group sizes were relatively small and the
ICP values were above 20 mmHg. Therefore,
there is a need for additional investigations
in experimental and clinical brain injury to
define the mechanism by which SBC
produces its effects, and for a larger,
randomized, controlled trial of SBC to
establish a workable protocol in severe
TBI.1,9,16 – 20
In conclusion, SBC, as applied in this
preliminary study – an easy and non-
invasive method of producing hypothermia –
cannot only reduce elevated ICP and
increase serum SOD levels, but can also
improve the prognosis without severe
complications in patients with severe TBI.
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